For research use only. Not for therapeutic Use.
Equol is a non-<wbr></wbr>steroidal estrogen produced from the metabolism of the isoflavonoid phytoestrogen daidzein by human intestinal microflora. It is a chiral molecule that exists in two enantiomeric forms. In contrast to the estrogen receptor (ER) selectivity of (S)-<wbr></wbr>equol , (R)-<wbr></wbr>equol is a weaker ER agonist that binds to ERα and ERβ with K<sub>i</sub> values of 27.4 and 15.4 nM, respectively. The (R)-<wbr></wbr>enantiomer demonstrates higher ER agonist activity at ERα compared to ERβ (EC<sub>50</sub> = 66 and 330 nM, respectively).
Catalog Number | R033747 |
CAS Number | 221054-79-1 |
Synonyms | (+)-Equol;Isoequol |
Molecular Formula | C15H14O3 |
Purity | ≥95% |
Target | Estrogen Receptor/ERR |
Storage | -20°C |
InChI | InChI=1S/C15H14O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-6,8,12,16-17H,7,9H2/t12-/m0/s1 |
InChIKey | ADFCQWZHKCXPAJ-LBPRGKRZSA-N |
SMILES | OC1=CC=C2C(OC[C@@H](C3=CC=C(O)C=C3)C2)=C1 |
Reference | 1.Setchell, K.D.R.,Clerici, C.,Lephart, E.D., et al. S-equol, a potent ligand for estrogen receptor ß, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. American Journal of Clinical Nutrition |